Ketamine Therapy for OCD: A Realistic Look
Obsessive-compulsive disorder is one of the harder conditions in psychiatry: first-line treatments (SSRIs at high doses and exposure and response prevention therapy) help many people, but a substantial minority get limited relief even after years of trying. That's exactly the population now showing up at ketamine clinics — so it's worth being clear-eyed about what the evidence actually supports.
The research, honestly summarized
The OCD evidence base is the smallest of the conditions ketamine is commonly offered for:
- The best-known study is a 2013 randomized crossover trial (Rodriguez and colleagues, Columbia) in unmedicated adults with OCD. A single ketamine infusion produced rapid drops in obsessions — half of participants still met treatment-response criteria a full week later, versus none who received placebo. Notably, this was in people with near-constant intrusive thoughts.
- An earlier open trial in more treatment-resistant, medicated patients found only brief, modest effects that faded within days.
- Since then, work has focused less on ketamine alone and more on ketamine as a springboard for therapy — using the post-infusion window to intensify exposure and response prevention (ERP). Small studies pairing a single infusion with condensed ERP have reported longer-lasting gains than infusion alone.
The pattern that emerges: ketamine can interrupt obsessional thinking quickly — sometimes within hours — but on its own the relief tends to be measured in days, not months. That's a shorter tail than in depression.
Why the ketamine-plus-ERP model makes sense
ERP works by having you face triggers without performing compulsions until the anxiety fades and the brain relearns. It's effective but grueling, and dropout is common. The theory behind combining it with ketamine: in the days after a dose, the brain's capacity for forming new associations (synaptic plasticity) appears elevated, potentially making exposure work stick better and feel more tolerable.
Practically, this means the most interesting question to ask a clinic isn't "do you treat OCD?" but:
"Do you coordinate with an ERP therapist, or schedule therapy in the days after infusions?"
A clinic that offers infusions with no therapy plan for OCD is offering you the version of treatment with the weakest evidence. Our clinic-selection guide covers more questions like this.
What a course of treatment looks like
There's no standardized OCD protocol; most clinics adapt their depression structure:
- IV infusions around 0.5 mg/kg over 40 minutes (see IV vs. IM for route trade-offs)
- Either a single infusion paired with intensive ERP, or a series of about six with therapy interwoven
- Symptom tracking with the Y-BOCS scale — ask whether the clinic measures this; good ones do
If you're also depressed — very common with OCD — you sit in the strongest evidence zone, since ketamine's depression data is robust and obsessive symptoms often ease as mood lifts.
Costs, coverage, and expectations
OCD treatment with ketamine is off-label, so the drug won't be covered by insurance, and Spravato's approval doesn't extend to OCD. The therapy component (ERP with a licensed therapist) often is billable as ordinary psychotherapy — a meaningful offset. See our insurance guide and cost breakdown.
Set expectations accordingly: this is a reasonable experimental option after first-line treatments have genuinely been tried — meaning an adequate SSRI trial at OCD-level doses and a real course of ERP — not a substitute for them. Any clinic pitching ketamine as a first-line OCD cure is a clinic to walk away from.
Bottom line
For OCD, ketamine is best understood as a fast-acting but short-lived circuit breaker — most promising when the quiet window it creates is used deliberately for exposure therapy. If that model appeals to you, look for clinics with an actual therapy partnership rather than infusions alone. You can browse clinics in our directory and contact them directly to ask how they handle OCD specifically.